sarscov
newli
identifi
coronaviru
caus
sever
acut
respiratori
syndrom
sar
current
effect
method
avail
prophylaxi
treatment
sarscov
infect
present
studi
influenc
small
interf
rna
sirna
sarscov
nucleocapsid
n
protein
express
detect
cultur
cell
mous
muscl
four
sirna
express
cassett
driven
mous
promot
target
sarscov
n
gene
prepar
inhibitori
effect
express
n
enhanc
green
fluoresc
protein
egfp
fusion
protein
observ
candid
sirna
prove
downregul
n
egfp
express
activ
sequencespecif
manner
express
vector
sirna
construct
confirm
reduc
n
egfp
express
effici
cultur
cell
adult
mous
muscl
find
suggest
sirna
provid
basi
prophylaxi
therapi
sarscov
infect
human
sever
acut
respiratori
syndrom
sar
emerg
infecti
diseas
human
appear
china
novemb
spread
countri
earli
etiolog
agent
sar
identifi
coronaviru
cov
sequenc
analysi
reveal
sarscov
distinct
known
human
coronavirus
two
previous
identifi
human
cov
associ
mild
upper
respiratori
tract
diseas
wherea
novel
sarscov
appear
first
human
coronaviru
respons
sever
diseas
human
cov
encod
common
set
structur
compon
consist
nucleocapsid
protein
n
three
integr
membran
protein
name
spike
protein
membran
protein
envelop
protein
e
protein
play
essenti
role
mediat
receptor
bind
intern
viru
one
major
antigen
viru
e
protein
essenti
virion
assembl
n
protein
bind
defin
packag
signal
viral
genom
rna
lead
format
helic
nucleocapsid
rna
interfer
rnai
process
doublestrand
rna
dsrna
induc
posttranscript
degrad
homolog
transcript
observ
varieti
organ
includ
plant
fungi
insect
drosophila
mammal
believ
evolv
host
defens
mechan
direct
transpos
element
infecti
virus
mani
studi
prove
sirna
significantli
suppress
gene
express
expos
mammalian
cell
vitro
moreov
number
group
demonstr
effect
silenc
endogen
gene
transgen
express
vivo
find
rais
possibl
rnai
might
advanc
field
therapeut
approach
viru
infect
studi
screen
express
cassettebas
sirna
target
n
sequenc
sarscov
significantli
suppress
express
sarscov
n
protein
cultur
cell
sequencespecif
manner
furthermor
sirna
express
vector
construct
prove
effect
silenc
express
sarscov
n
protein
adult
mous
muscl
base
pair
nonestop
codon
fragment
sarscov
n
gene
synthes
accord
publish
sequenc
genbank
access
number
nucleoprotein
code
region
nt
nt
full
length
sarscov
genom
use
templat
amplifi
dna
fragment
construct
n
enhanc
green
fluoresc
protein
egfp
fusion
protein
express
plasmid
forward
primer
revers
primer
underlin
sequenc
ecori
bamhi
site
respect
ecoribamhi
fragment
transfer
vector
clontech
yield
recombin
pnegfp
construct
n
gene
locat
upstream
egfp
insert
fragment
verifi
restrict
endonucleas
digest
dna
sequenc
select
sirna
target
site
prepar
sirna
express
cassett
sirna
target
sarscov
n
sequenc
select
base
follow
guidelin
nucleotid
follow
aa
dinucleotid
sequenc
begin
g
prefer
rna
polymeras
iii
transcript
sequenc
contain
gc
sequenc
contain
run
avoid
earli
termin
rna
polymeras
iii
transcript
sequenc
homolog
known
human
gene
select
sirna
target
site
shown
tabl
target
site
specif
sarscov
gene
target
site
mutant
sequenc
binucleotid
site
c
site
g
revers
serv
control
analysi
specif
sirna
pcr
base
sirna
express
cassett
contain
promot
sens
strand
sirna
loop
antisens
strand
sirna
stretch
six
deoxythymidin
poli
amplifi
twostep
pcr
describ
castanotto
gou
fig
primer
complementari
nt
end
murin
promot
use
pcr
procedur
first
round
pcr
plasmid
contain
mous
promot
ambion
use
templat
revers
primer
contain
loop
antisens
sequenc
sirna
target
site
complementari
sequenc
last
nt
mous
promot
pcr
amplif
use
pfu
dna
polymeras
carri
follow
min
cycl
min
one
microlit
first
pcr
product
reamplifi
use
mixtur
taq
pfu
dna
polymeras
amplif
condit
forward
primer
first
round
pcr
revers
primer
contain
poli
sens
strand
sirna
target
site
complementari
sequenc
loop
addit
mous
promot
amplifi
control
sirna
screen
second
round
pcr
product
purifi
use
qiaquick
pcr
purif
kit
qiagen
revers
primer
list
tabl
tabl
sirna
target
sequenc
revers
primer
prepar
sirna
express
cassett
sirna
sequenc
revers
primer
sequenc
twostep
pcr
procedur
sirna
express
cassett
describ
text
pcr
product
consist
mous
promot
short
hairpin
dna
termin
sequenc
six
thymidin
b
sirna
express
cassett
prepar
two
round
pcr
lane
pcr
product
sirna
express
cassett
respect
lane
pcr
product
express
cassett
lane
pcr
product
express
cassett
lane
pcr
product
mous
promot
cho
vero
cell
cultur
modifi
medium
supplement
fetal
bovin
serum
fb
mm
l
lglutamin
uml
penicillin
lgml
streptomycin
twentyfour
hour
transfect
confluent
cell
trypsin
cell
plate
format
fresh
cultur
medium
without
antibiot
plasmid
pnegfp
lg
cotransfect
sirna
express
cassett
lg
use
lipofectamin
invitrogen
accord
instruct
variou
time
point
cell
examin
express
egfp
fluoresc
microscop
olympu
express
sarscov
n
protein
detect
western
blot
realtim
pcr
analys
observ
inhibitori
effect
sirna
express
cassett
express
sarscov
n
egfp
protein
activ
sirna
express
cassett
target
sarscov
n
sequenc
insert
vector
takara
use
taclon
techniqu
correct
sequenc
verifi
dna
sequenc
result
sirna
express
plasmid
use
studi
sequenc
specif
analysi
sirna
plasmid
pcihbc
use
unrel
viral
gene
express
control
construct
insert
hepat
b
viru
core
antigen
hbcag
dna
sequenc
eukaryot
express
vector
pcineo
promega
cell
plate
mm
dish
cotransfect
respect
plasmid
effect
sirna
express
sarscov
n
protein
murin
skelet
muscl
plasmid
pnegfp
purifi
use
qiafilter
plasmid
mega
kit
qiagen
mix
respect
polyvinyl
pyrrolidon
pvp
mw
sigma
pb
final
concentr
gl
plasmid
later
use
muscl
inject
mice
sixweek
old
femal
balbc
mice
xiperbikai
experiment
anim
co
ltd
shanghai
randomli
divid
two
group
four
mice
group
experiment
group
inject
pnegfp
side
tibiali
anterior
muscl
control
group
receiv
pnegfp
day
postinject
one
mous
per
group
sacrif
tibiali
anterior
muscl
isol
n
egfp
express
analys
total
rna
transfect
cell
extract
use
trizol
reagent
gibco
accord
instruct
treat
rnasefre
dnase
promega
make
sure
plasmid
pnegfp
deriv
dna
present
total
rna
lg
total
rna
check
pcr
use
primer
primer
gatgcctcag
prior
revers
transcript
fragment
correspond
nt
sarscov
n
gene
obtain
one
microgramm
total
rna
subject
revers
transcript
reaction
u
amv
revers
transcriptas
takara
pmol
oligo
dt
primer
reaction
mixtur
min
rt
product
inactiv
heat
min
subject
realtim
pcr
analysi
use
sybr
premix
ex
taqe
system
takara
realtim
pcr
rt
product
amplifi
reaction
volum
contain
pmol
primer
primer
sybr
premix
ex
taqe
buffer
includ
sybr
green
reagent
taq
dna
polymeras
dntp
primer
sarscov
n
use
pcr
total
rna
follow
denatur
step
amplif
reaction
perform
cycl
realtim
quantit
lightcycler
system
roch
sampl
run
triplic
six
serial
dilut
sampl
ecoribamhi
fragment
n
sequenc
vari
copi
reaction
use
creat
standard
curv
quantit
sar
n
cdna
concentr
rt
product
analysi
sarscov
n
mrna
mous
skelet
muscl
tibiali
anterior
muscl
freezethaw
homogen
cellular
rna
extract
describ
cell
lyze
use
lysi
buffer
triton
mm
edta
mm
trishcl
ph
lgml
leupeptin
mm
phenylmethylsulfonyl
fluorid
cell
lysat
separ
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
electrophoret
transfer
nitrocellulos
membran
primari
antibodi
use
detect
specif
protein
follow
antisarscov
n
posit
sera
convalesc
sar
patient
dilut
antihbcag
posit
sera
acut
hepat
b
patient
dilut
antibactin
monoclon
antibodi
santacruz
dilut
secondari
antibodi
detect
perform
use
alkalin
phosphataseconjug
goat
antihuman
igg
horseradish
peroxidaseconjug
goat
antimous
igg
immunoreact
band
visual
nitroblu
tetrazolium
nbtbcip
pierc
dab
h
detect
sarscov
n
protein
mous
skelet
muscl
isol
tibiali
anterior
muscl
freezethaw
homogen
extract
protein
analyz
procedur
similar
describ
construct
sirna
express
cassett
procedur
consist
two
round
pcr
use
describ
castanotto
gou
result
pcr
product
includ
mous
promot
sens
sequenc
loop
antisens
sequenc
follow
pol
iii
termin
sequenc
poli
fig
use
method
six
sirna
express
cassett
prepar
correct
predict
molecular
weight
fig
sirna
express
cassett
plasmid
pnegfp
transfect
cho
vero
cell
either
alon
along
sirna
express
cassett
respect
variou
time
point
posttransfect
effect
sirna
egfp
express
monitor
fluoresc
microscop
result
show
four
sirna
express
cassett
target
n
gene
could
inhibit
express
egfp
extent
compar
cell
transfect
plasmid
pnegfp
alon
especi
express
cassett
express
cassett
target
nt
n
sequenc
effect
weak
fluoresc
observ
h
posttransfect
signific
inhibit
egfp
express
observ
time
cell
cotransfect
control
construct
mous
promot
sirna
express
cassett
given
inhibit
express
cassett
egfp
express
mutant
version
two
nucleotid
revers
prepar
gave
littl
influenc
egfp
express
western
blot
semiquantit
realtim
pcr
carri
determin
inhibitori
effect
sirna
sarscov
n
gene
express
western
blot
demonstr
inhibit
n
gene
shrna
n
protein
similar
egfp
express
suppress
effect
sirna
signific
control
construct
mutant
littl
effect
fig
realtim
pcr
assay
also
show
four
sirna
express
cassett
could
downregul
mrna
transcript
n
gene
three
control
construct
cotransfect
pnegfp
margin
effect
mrna
n
gene
fig
therefor
sirna
select
studi
sirna
express
vector
construct
insert
express
cassett
vector
fig
recombin
vector
cotransfect
cultur
cell
negfp
express
plasmid
hepat
b
viru
core
antigen
express
plasmid
adopt
exogen
gene
control
assay
shown
fig
c
sirna
express
vector
inhibit
n
egfp
express
cell
dosedepend
manner
lg
administ
n
egfp
express
significantli
suppress
hbcag
express
influenc
silenc
negfp
sirna
express
vector
mous
muscl
mous
model
express
negfp
fusion
protein
skelet
muscl
use
test
potenti
anitsarscov
activ
sirna
vivo
intramuscularli
coinject
negfp
express
plasmid
sirna
express
plasmid
mice
found
plasmid
could
reduc
express
egfp
n
protein
significantli
inhibitori
effect
last
day
entir
observ
period
fig
realtim
pcr
analysi
show
mrna
level
sarscov
n
mous
muscl
reduc
rel
coinject
pnegfp
control
plasmid
day
sirna
deliveri
respect
small
interf
rna
sirna
mediat
rnai
short
nt
dsrna
duplex
inhibit
gene
express
induc
sequencespecif
degrad
homolog
rna
may
stand
new
promis
method
protect
viral
infect
sever
method
introduc
sirna
prepar
chemic
synthesi
rna
polymeras
direct
vitro
transcript
short
hairpin
rna
shrna
express
dna
vector
pcrbase
shrna
express
cassett
may
repres
one
timeand
laborsav
method
especi
identif
specif
effici
target
site
addit
pcr
product
easili
insert
vector
ta
clone
suitabl
restrict
enzym
site
tag
present
primer
direct
clone
plasmid
vector
also
feasibl
n
protein
sarscov
key
protein
format
helic
nucleocapsid
cytoplasm
conserv
structur
protein
make
ideal
target
rna
interfer
studi
four
sirna
candid
site
target
sarscov
n
sequenc
select
mous
promot
regul
sirna
express
cassett
construct
four
candid
sirna
gave
reduct
egfp
express
cultur
cell
show
signific
effect
western
blot
demonstr
similar
inhibitori
effect
n
protein
egfp
semiquantit
pcr
confirm
downregul
mrna
n
gene
effici
three
sirna
gene
intervent
sequenc
specif
import
practic
applic
know
mammalian
cell
dsrna
base
pair
longer
trigger
interferon
respons
intrins
sequencenonspecif
observ
control
pcr
product
includ
promot
sarscov
starget
sirna
express
construct
littl
influenc
negfp
express
importantli
binucleotid
revers
mutant
sirna
inhibitori
activ
negfp
express
result
indic
inhibit
negfp
express
sirna
sequencespecif
requir
homolog
sirna
gene
target
consequ
interferon
respons
induc
dsrna
sirna
express
vector
construct
insert
pcr
product
vector
observ
cultur
cell
plasmid
could
significantli
suppress
negfp
express
dosedepend
manner
express
anoth
viral
protein
hbcag
chang
express
negfp
hbcag
driven
transcript
control
element
cmv
immediateearli
promoterenhanc
downregul
viral
rna
cytokin
sequencespecif
result
suggest
inhibitori
effect
sirna
sarscov
n
express
due
ifn
respons
sequencedepend
sirna
mechan
determin
potenti
biolog
activ
sirna
vivo
establish
mous
model
express
negfp
skelet
muscl
muscl
cell
excel
exogen
gene
express
exampl
direct
intramuscular
dna
vaccin
inject
could
lead
antigen
express
muscl
cell
induct
system
immun
respons
host
analysi
protein
mrna
level
show
cultur
cell
sirna
could
downregul
n
egfp
express
mous
muscl
effect
last
entir
observ
period
though
lower
dose
sirna
develop
less
suppress
activ
n
egfp
express
still
behav
signific
inhibit
lg
instead
lg
administ
mrna
n
gene
reduc
differ
time
point
respect
data
shown
although
evalu
activ
sirna
respiratori
tract
relev
target
sarscov
infect
sirna
seem
function
silenc
n
protein
express
vivo
base
data
mous
muscl
cultur
cell
especi
vero
cell
support
sarscov
replic
sirna
promis
develop
antivir
agent
human
use
especi
combin
sever
sirna
specif
differ
gene
region
deliv
appropri
carrier
cation
polym
viru
vector
proper
modif
linkag
cholesterol
character
sarscov
infect
recombin
vaccinia
viru
vector
may
attract
altern
sirna
deliveri
recent
sirna
target
polymeras
sequenc
report
silenc
gene
express
inhibit
sarscov
replic
mammalian
cell
effici
togeth
data
consider
sirna
may
possibl
develop
antisar
agent
summari
screen
sirna
candid
target
sarscov
n
gene
base
sirna
express
cassett
identifi
sirna
could
effici
specif
inhibit
express
sarscov
n
protein
human
cell
monkey
vero
cell
inhibitori
activ
durabl
effect
sirna
n
express
confirm
mous
muscl
present
data
suggest
sirna
potenti
valu
prophylaxi
treatment
sarscov
infect
human
